rs796052908

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_002693.3(POLG):​c.1270_1271del​(p.Leu424GlyfsTer29) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,734 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β˜…β˜…). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

POLG
NM_002693.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 8.86
Variant links:
Genes affected
POLG (HGNC:9179): (DNA polymerase gamma, catalytic subunit) Mitochondrial DNA polymerase is heterotrimeric, consisting of a homodimer of accessory subunits plus a catalytic subunit. The protein encoded by this gene is the catalytic subunit of mitochondrial DNA polymerase. The encoded protein contains a polyglutamine tract near its N-terminus that may be polymorphic. Defects in this gene are a cause of progressive external ophthalmoplegia with mitochondrial DNA deletions 1 (PEOA1), sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO), Alpers-Huttenlocher syndrome (AHS), and mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-89327328-CAG-C is Pathogenic according to our data. Variant chr15-89327328-CAG-C is described in ClinVar as [Pathogenic]. Clinvar id is 206608.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-89327328-CAG-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POLGNM_002693.3 linkuse as main transcriptc.1270_1271del p.Leu424GlyfsTer29 frameshift_variant 7/23 ENST00000268124.11 NP_002684.1
POLGARFNM_001406557.1 linkuse as main transcriptc.*542_*543del 3_prime_UTR_variant 7/23 NP_001393486.1
POLGNM_001126131.2 linkuse as main transcriptc.1270_1271del p.Leu424GlyfsTer29 frameshift_variant 7/23 NP_001119603.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POLGENST00000268124.11 linkuse as main transcriptc.1270_1271del p.Leu424GlyfsTer29 frameshift_variant 7/231 NM_002693.3 ENSP00000268124 P1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152224
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000399
AC:
1
AN:
250710
Hom.:
0
AF XY:
0.00000737
AC XY:
1
AN XY:
135686
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000882
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461510
Hom.:
0
AF XY:
0.00000413
AC XY:
3
AN XY:
727056
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152224
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000264
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Progressive sclerosing poliodystrophy Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsJan 03, 2024- -
Pathogenic, criteria provided, single submitterclinical testingWong Mito Lab, Molecular and Human Genetics, Baylor College of MedicineOct 01, 2018The NM_002693.2:c.1270_1271del (NP_002684.1:p.Leu424GlyfsTer29) [GRCH38: NC_000015.10:g.89327331_89327332del] variant in POLG gene is interpretated to be a Pathogenic based on ACMG guidelines (PMID: 25741868). This variant has been reported in PMID:12707443 . This variant meets the following evidence codes reported in the ACMG-guideline. PVS1:This variant is a predicted null variant in POLG where loss of function is a known mechanism of disease. PM2:This variant is absent in key population databases. PM3:Detected in trans with a pathogenic variant for Mitochondrial DNA depletion syndrome 4A (Alpers type) which is a recessive disorder. PM4:This variant causes alteration in the length of expressed protein. PP5:Reputable source(s) suggest that the variant is pathogenic. Based on the evidence criteria codes applied, the variant is suggested to be Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 19, 2023This sequence change creates a premature translational stop signal (p.Leu424Glyfs*29) in the POLG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POLG are known to be pathogenic (PMID: 18546365). This variant is present in population databases (rs796052908, gnomAD 0.0009%). This premature translational stop signal has been observed in individuals with autosomal recessive POLG-related conditions (PMID: 12707443, 18546365). ClinVar contains an entry for this variant (Variation ID: 206608). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingGeneDxApr 05, 2017c.1270_1271delCT: p.Leu424GlyfsX29 (L424Gfsx29) in exon 7 of the POLG gene (NM_002693.2). The normal sequence with the bases that are deleted in braces is: GACT{CT}GGCC.The c.1270_1271delCT mutation in the POLG gene has been reported in a child with Alpers syndrome and in an individual with adult-onset progressive external ophthalmoplegia (PEO) and multiple mtDNA deletions, both of whom had a second identified mutation in the POLG gene (Wong et al., 2008; Agostino et al., 2003). The deletion causes a frameshift starting with codon Leucine 424, changes this amino acid to a Glycine residue and creates a premature Stop codon at position 29 of the new reading frame, denoted p.Leu424GlyfsX29. This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is found in INFANT-EPI panel(s). -
Pathogenic, criteria provided, single submitterclinical testingAthena DiagnosticsJun 07, 2021This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in trans with a pathogenic POLG variant in at least one individual with clinical features associated with this gene. -
Generalized epilepsy;C0028754:Obesity;C0557874:Global developmental delay Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingClaritas GenomicsNov 28, 2016The c.1270_1271delCT (p.Leu424Glyfs*29) missense variant in the POLG gene is previously reported in the literature and is expected to be causative of disease, typically as a recessive disorder. Homozygous or compound heterozygous pathogenic variants in this gene are associated with a range of mitochondrial conditions including, Alpers-Huttenlocher syndrome, childhood myocerebrohepatopathy syndrome (MCHS), myoclonic epilepsy myopathy sensory ataxia (MEMSA), mitochondrial DNA depletion syndrome 4B (MNGIE type), mitochondrial ataxia neuropathy spectrum (includes SANDO and SCAE) and progressive external ophthalmoplegia. Progressive external ophthalmoplegia can also be inherited in an autosomal dominant manner. These conditions are known to have variable expressivity, including a wide range in age of onset as well as reduced penetrance. This deletion of two basepairs results in a shift in the reading frame at position p.Leu424 and introduces a premature stop codon 28 positions downstream, which is predicted to result in protein truncation or nonsense mediated decay. It has been reported in the compound heterozygous state in one individual with adult-onset progressive external ophthalmoplegia and one child with Alpers syndrome. It has not been observed in the 1000 Genomes, ExAC, or NHLBI Exome Sequencing Project control databases. Therefore, due to the predicted loss-of-function effect of the variant and prior reports in the literature, it is classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs796052908; hg19: chr15-89870559; API